


Healthcare Industry NewsFeed
HSMN NewsFeed - 10 May 2013
Boston Scientific Receives CE Mark Approval For The Rhythmia(TM) Mapping System
Boston Scientific Receives CE Mark Approval For The Rhythmia(TM) Mapping System
HSMN NewsFeed - 9 May 2013
Ochsner Medical Center Implants 1st SynCardia Total Artificial Heart in Gulf South Region
Ochsner Medical Center Implants 1st SynCardia Total Artificial Heart in Gulf South Region
HSMN NewsFeed - 9 May 2013
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
HSMN NewsFeed - 9 May 2013
Sunshine Heart, Inc. Announces First Patient Implanted in C-Pulse System European Post-Market Study
Sunshine Heart, Inc. Announces First Patient Implanted in C-Pulse System European Post-Market Study
HSMN NewsFeed - 8 May 2013
Surgeons Implant Magnetic Growing Rods In Groundbreaking Treatment For Early-Onset Scoliosis
Surgeons Implant Magnetic Growing Rods In Groundbreaking Treatment For Early-Onset Scoliosis
HSMN NewsFeed - 8 May 2013
Toshiba Infinix-i System Displays Radiation Dose Exposure to Improve Patient Safety
Toshiba Infinix-i System Displays Radiation Dose Exposure to Improve Patient Safety
HSMN NewsFeed - 7 May 2013
3M Unitek and Rocky Mountain Orthodontics Settle Patent Infringement Litigation
3M Unitek and Rocky Mountain Orthodontics Settle Patent Infringement Litigation
HSMN NewsFeed - 7 May 2013
Corgenix Gains CE Mark for ReLASV(R) Antigen Rapid Test for Diagnosis of Lassa Fever
Corgenix Gains CE Mark for ReLASV(R) Antigen Rapid Test for Diagnosis of Lassa Fever
HSMN NewsFeed - 7 May 2013
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
HSMN NewsFeed - 7 May 2013
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
HSMN NewsFeed - 7 May 2013
ASTRO and AUA Issue Joint Guideline for Radiation Therapy After Prostatectomy
ASTRO and AUA Issue Joint Guideline for Radiation Therapy After Prostatectomy
HSMN NewsFeed - 6 May 2013
ETView Medical, Ltd. and Mercury Medical, Inc. (Mercury) Execute Distribution Agreement
ETView Medical, Ltd. and Mercury Medical, Inc. (Mercury) Execute Distribution Agreement
HSMN NewsFeed - 2 May 2013
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Orthopedic Power Tools
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Orthopedic Power Tools
HSMN NewsFeed - 2 May 2013
Hyperion Therapeutics Exercises Option to Acquire Rights to BUPHENYL(R) and AMMONUL(R)
Hyperion Therapeutics Exercises Option to Acquire Rights to BUPHENYL(R) and AMMONUL(R)
HSMN NewsFeed - 1 May 2013
Ultragenyx Appoints Eric Yuen, MD as Chief Medical Officer and Senior Vice President
Ultragenyx Appoints Eric Yuen, MD as Chief Medical Officer and Senior Vice President
HSMN NewsFeed - 1 May 2013
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
HSMN NewsFeed - 1 May 2013
BiO2 Medical's IDE Application for the Angel(TM) Catheter Receives FDA Approval
BiO2 Medical's IDE Application for the Angel(TM) Catheter Receives FDA Approval
HSMN NewsFeed - 30 Apr 2013
Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of Directors
Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of Directors
HSMN NewsFeed - 30 Apr 2013
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
HSMN NewsFeed - 30 Apr 2013
St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
HSMN NewsFeed - 29 Apr 2013
Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
HSMN NewsFeed - 29 Apr 2013
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
HSMN NewsFeed - 29 Apr 2013
Teleflex Receives FDA 510(k) Clearance for Next Generation Vascular Positioning System(R)
Teleflex Receives FDA 510(k) Clearance for Next Generation Vascular Positioning System(R)
